Categorized | Colorado News, National News, News

Cigna Offers Aid to Diabetics

Type 1 Diabetics require daily doses of insulin to sustain life.  Not a “new drug”, insulin was invented in 1922.

U.S. lawmakers have focused on healthcare companies regarding rising costs of medicine.  Powerful committees in Congress held hearings in January on insulin affordability.

The annual cost of insulin for treating a type 1 diabetes patient in the United States nearly doubled to $5,705 in 2016 from $2,864 in 2012, according to a recent study.

Health insurer Cigna Corp on Wednesday announced a program aimed at ensuring some diabetes patients pay no more than $25 for a 30-day supply of insulin in response to heightened public scrutiny over soaring prices of the life-saving drug.

Cigna, which acquired pharmacy benefits manager Express Scripts last year, said it was partnering with insulin manufacturers to lower copayments to $25 at the point of sale.

Source: Reuters

 

INTERESTED IN SPONSORING?

 

Contact Alexis Hertel at  

ahertel@hmo-info.com

(303) 322-2228

Thank You For Your Loyalty.

HCCA, publishers of the Colorado Managed Care Newsletter, began reporting on the financing of healthcare in Colorado in December of 1983. As we begin our 35th year, we are grateful for the opportunity to be one of your sources of information in this ever-changing, healthcare market.